Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Anatomic | 3 | 2020 | 103 | 1.120 |
Why?
|
| Computer-Aided Design | 2 | 2020 | 20 | 1.080 |
Why?
|
| Contrast Media | 8 | 2021 | 461 | 0.880 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 83 | 0.740 |
Why?
|
| Indocyanine Green | 3 | 2023 | 53 | 0.720 |
Why?
|
| Optical Imaging | 2 | 2018 | 72 | 0.670 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 81 | 0.650 |
Why?
|
| X-Ray Microtomography | 3 | 2021 | 96 | 0.640 |
Why?
|
| Child Abuse | 1 | 2021 | 198 | 0.560 |
Why?
|
| Phantoms, Imaging | 2 | 2018 | 128 | 0.550 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2021 | 379 | 0.490 |
Why?
|
| Computer Peripherals | 1 | 2013 | 4 | 0.420 |
Why?
|
| Nanoparticles | 5 | 2021 | 267 | 0.410 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 52 | 0.400 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 228 | 0.370 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 460 | 0.370 |
Why?
|
| Pediatrics | 1 | 2020 | 1203 | 0.340 |
Why?
|
| Aortic Rupture | 2 | 2021 | 115 | 0.300 |
Why?
|
| Hepatoblastoma | 2 | 2022 | 186 | 0.300 |
Why?
|
| Placenta | 3 | 2019 | 509 | 0.300 |
Why?
|
| Gadolinium | 3 | 2019 | 110 | 0.280 |
Why?
|
| Moyamoya Disease | 2 | 2025 | 41 | 0.270 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 1351 | 0.230 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 127 | 0.220 |
Why?
|
| Animals | 19 | 2025 | 33184 | 0.210 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2025 | 183 | 0.210 |
Why?
|
| Mice | 15 | 2025 | 17629 | 0.210 |
Why?
|
| Actins | 1 | 2025 | 313 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3690 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2036 | 0.180 |
Why?
|
| Angiography | 2 | 2021 | 191 | 0.180 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 76 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 93 | 0.180 |
Why?
|
| Indans | 1 | 2021 | 51 | 0.180 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2023 | 153 | 0.170 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.170 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 30 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2021 | 51 | 0.170 |
Why?
|
| Disposable Equipment | 1 | 2020 | 15 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 1 | 2021 | 112 | 0.170 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 123 | 0.170 |
Why?
|
| Aortography | 1 | 2021 | 159 | 0.160 |
Why?
|
| Natural Language Processing | 1 | 2021 | 72 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 155 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2020 | 86 | 0.160 |
Why?
|
| Liposomes | 5 | 2019 | 196 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 50 | 0.160 |
Why?
|
| Cytosol | 1 | 2019 | 139 | 0.150 |
Why?
|
| Iodine | 2 | 2016 | 22 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 209 | 0.150 |
Why?
|
| Piperazines | 1 | 2021 | 255 | 0.150 |
Why?
|
| Hindlimb | 1 | 2018 | 75 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 386 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 665 | 0.140 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 26 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 224 | 0.140 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4432 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 65 | 0.140 |
Why?
|
| Chickens | 1 | 2017 | 284 | 0.130 |
Why?
|
| Aorta | 1 | 2021 | 522 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 588 | 0.130 |
Why?
|
| Skull | 1 | 2018 | 147 | 0.130 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 361 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2021 | 557 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 677 | 0.130 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2017 | 22 | 0.130 |
Why?
|
| Osteotomy | 1 | 2017 | 46 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 727 | 0.130 |
Why?
|
| Cattle | 1 | 2017 | 537 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 233 | 0.130 |
Why?
|
| Child | 5 | 2021 | 25086 | 0.120 |
Why?
|
| Echo-Planar Imaging | 1 | 2016 | 21 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 145 | 0.120 |
Why?
|
| Algorithms | 2 | 2021 | 1623 | 0.120 |
Why?
|
| Dog Diseases | 1 | 2016 | 58 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 134 | 0.110 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2014 | 14 | 0.110 |
Why?
|
| DNA | 1 | 2019 | 1424 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 836 | 0.110 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 80 | 0.110 |
Why?
|
| Amyloid | 1 | 2014 | 69 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2021 | 778 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2013 | 81 | 0.100 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 139 | 0.100 |
Why?
|
| Humans | 15 | 2025 | 126518 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1017 | 0.100 |
Why?
|
| Brain | 2 | 2015 | 3039 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 578 | 0.100 |
Why?
|
| Uterus | 1 | 2016 | 532 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1570 | 0.090 |
Why?
|
| Electron Microscope Tomography | 1 | 2012 | 24 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 574 | 0.090 |
Why?
|
| Female | 12 | 2025 | 68161 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2016 | 537 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2012 | 167 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2021 | 4482 | 0.090 |
Why?
|
| Cryoelectron Microscopy | 1 | 2012 | 226 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 968 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 3503 | 0.070 |
Why?
|
| Ligands | 2 | 2021 | 477 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 565 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4512 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2021 | 14338 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3716 | 0.070 |
Why?
|
| Male | 7 | 2025 | 62339 | 0.070 |
Why?
|
| Heterografts | 2 | 2017 | 190 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 946 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1495 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 2852 | 0.060 |
Why?
|
| United States | 1 | 2021 | 11253 | 0.060 |
Why?
|
| Niacinamide | 1 | 2025 | 30 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 12761 | 0.060 |
Why?
|
| Disease Progression | 2 | 2021 | 2104 | 0.060 |
Why?
|
| Glycolysis | 1 | 2025 | 168 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2025 | 228 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 16928 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2018 | 1056 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 850 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 245 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2021 | 31 | 0.040 |
Why?
|
| Liver | 2 | 2021 | 1763 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 81 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 306 | 0.040 |
Why?
|
| Protein Folding | 1 | 2021 | 214 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 194 | 0.040 |
Why?
|
| Drug Design | 1 | 2021 | 154 | 0.040 |
Why?
|
| Pregnancy | 3 | 2019 | 7411 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 136 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 180 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 731 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 372 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 30325 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 239 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 58 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 827 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1857 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1594 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2018 | 94 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 334 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 90 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 290 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1388 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 708 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 452 | 0.030 |
Why?
|
| Meglumine | 1 | 2016 | 16 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 570 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 76 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 822 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 229 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 80 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 109 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 628 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2193 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 601 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 741 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1197 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1129 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2017 | 201 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1813 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1662 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 989 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2014 | 130 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1937 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 446 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4937 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3388 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6098 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2313 | 0.020 |
Why?
|
| Lung | 1 | 2016 | 1522 | 0.020 |
Why?
|
| Software | 1 | 2012 | 711 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 10512 | 0.020 |
Why?
|